Breakpoints
By Society of Infectious Diseases Pharmacists
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Health & Fitness
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 23
Reviews: 0
Episodes: 116
Description
The SIDP Podcast
| Episode | Date |
|---|---|
|
#116 – SNAP Out of It: Rethinking Antistaphylococcal Penicillins for S. Aureus Bacteremia – The SNAP Trial PSSA/MSSA Results
|
May 04, 2025 |
|
#115 – Silver Lining of Shortages: Blood Culture Best Practices
|
Apr 25, 2025 |
|
#114 – Dosing Consult: Amoxicillin/Clavulanate
|
Apr 11, 2025 |
|
#113 – Ask ChatGPT: The Role of AI in Healthcare
|
Mar 28, 2025 |
|
#112 – Say It Ain't Steno: Stenotrophomonas maltophilia Review
|
Feb 28, 2025 |
|
#111 – Dosing Consult: Rifampin Part 2
|
Feb 14, 2025 |
|
#110 – A Bone to Pick: Biofilm Busters for Prosthetic Joint Infections
|
Jan 24, 2025 |
|
#109 – IDWeek 2024 Recap: Practice Changing Papers and ID Potpourri
|
Dec 27, 2024 |
|
#108 – IDWeek 2024 Recap: Late Breaker Abstracts and Stewardship Talks
|
Dec 20, 2024 |
|
#107 – Dosing Consult: Valganciclovir
|
Nov 29, 2024 |
|
#106 – Stewie Struggles: EHR Edition
|
Nov 08, 2024 |
|
#105 – Bringing Positive Vibes Only: Breaking News & Emerging Hypotheses for Gram-Positive Bacterial Infections
|
Oct 25, 2024 |
|
#104 – Dosing Consult: Rifampin Part 1
|
Oct 04, 2024 |
|
#103 – Dosing Consult: Daptomycin
|
Sep 06, 2024 |
|
#102 – Oh, the Places Stewardship Will Go! Best Practices for Outpatient Antibiotic Stewardship and Transitions of Care
|
Aug 23, 2024 |
|
#101 – BLING III: Does Continuous Infusion Make the Whole Place Shimmer
|
Aug 02, 2024 |
|
#100 – Tackling Tetracyclines: Breakpoints 100th Episode!
|
Jul 26, 2024 |
|
#99 – Don’t be CRABby: Acinetobacter baumannii review
|
Jun 28, 2024 |
|
#98 – Uncomplicated UTIs: Getting Uncomfortable with Uncertainty
|
May 24, 2024 |
|
#97 – Hot Topics: What Did You Miss in Infectious Diseases in 2023-2024 (LIVE from MAD-ID)
|
May 17, 2024 |
|
#96 – The Tortured Stewards & Surgeons Department
|
Apr 19, 2024 |
|
#95 – A to Z on R&D: Challenges and Solutions for Sustained Antimicrobial Drug Development
|
Mar 29, 2024 |
|
#94 – Lock, Stock, & Sterilize: Strategies to Optimize Antimicrobial Lock Therapy & Prevent/Treat Catheter-Related Bloodstream Infections
|
Mar 22, 2024 |
|
#93 – Global, Live Journal Club: Ceftobiprole for Complicated Staphylococcus aureus Bacteremia (ERADICATE Study)
|
Feb 23, 2024 |
|
#92 – Antibiotic Alchemy: Metallo-Beta-Lactamases
|
Feb 02, 2024 |
|
#91 – Teamwork Makes the Dream Work: Preparation Pearls for Stewardship and Microbiology Lab Accreditation Updates
|
Jan 19, 2024 |
|
#90 – IDWeek 2023 Recap: Pipeline Agents and Clinical Trials That May Change Your Practice
|
Jan 05, 2024 |
|
#89 – IDWeek 2023 Recap: Late Breaking Clinical Trials
|
Dec 22, 2023 |
|
#88 – Dosing Consult: Can we BID farewell to Q8H Metronidazole?
|
Dec 01, 2023 |
|
#87 – We Love T Cells: Updates in Cytomegalovirus
|
Nov 17, 2023 |
|
#86 – The Robin to Your Batman: Ensuring Adequate Beta-lactamase Inhibitor Exposure to Restore Beta-lactam Activity
|
Oct 20, 2023 |
|
#85 – Who You Gonna Call? Mythbusters! Antibiotic Myths for Infectious Diseases Clinicians
|
Sep 15, 2023 |
|
#84 – Antimicrobial Stewardship and Disaster Medicine: Perspectives from Ukraine
|
Aug 18, 2023 |
|
#83 – Dosing Consult: Sulfamethoxazole/trimethoprim
|
Jul 21, 2023 |
|
#82 – ID Literature Year in Review (LIVE from MAD-ID)
|
Jun 23, 2023 |
|
#81 – Making the Right Choice Easy: Antimicrobial Stewardship in the Emergency Department
|
Jun 16, 2023 |
|
#80 – Weighting on a Miracle: Understanding Unknowns of Dosing Children and Adults with Obesity
|
Jun 02, 2023 |
|
#79 – HAP & VAP: Let’s Clear the Air
|
May 26, 2023 |
|
#78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?
|
Apr 28, 2023 |
|
#77 – Breakpoints Talks Breakpoints: Non-fermenters
|
Apr 21, 2023 |
|
#76 – Breakpoints Talks Breakpoints: Fluoroquinolones
|
Apr 14, 2023 |
|
#75 – Breakpoints Talks Breakpoints: Aminoglycosides
|
Apr 07, 2023 |
|
#74 – Breakpoints Talks Breakpoints: Piperacillin/tazobactam
|
Mar 31, 2023 |
|
#73 – You’re a Breakpoint, Harry: Magical Insights from CLSI and USCAST
|
Mar 24, 2023 |
|
#72 – This Isn't Just a Phage: A Discussion on Bacteriophage Therapy
|
Mar 17, 2023 |
|
#71 – This is a Potential Breakup Song: Controversies in the Management of Infective Endocarditis
|
Feb 17, 2023 |
|
#70 – Stewardship Struggles
|
Jan 20, 2023 |
|
#69 – IDWeek 2022 Recap: Practice Changing Publications – Midnights Edition
|
Dec 30, 2022 |
|
#68 – IDWeek 2022 Recap: Late Breaking Trials and Pipeline Antibacterials
|
Dec 23, 2022 |
|
#67 – Nixing the Nidus: Managing Retained Sources in Prosthetic Joint Infections
|
Nov 25, 2022 |
|
#66 – The Swinging PEN-dulum: Evolving Approaches to Cephalosporin Use in Penicillin Allergic Patients
|
Nov 18, 2022 |
|
#65 – Into the Unknown: Exploring Fever of Unknown Origin with Febrile Podcast
|
Oct 14, 2022 |
|
#64 – Putting the Fun in Fungi: A Fun-guide to New Antifungals
|
Sep 23, 2022 |
|
#63 – I Never Metapneumovirus that Required Antibiotics: Prevention & Treatment of Common Respiratory Viruses in Adults
|
Sep 16, 2022 |
|
#62 – Novel TheraPOOtics: The Microbiome, C. difficile, and LBPs
|
Aug 26, 2022 |
|
#61 – Dosing Consult: Linezolid Therapeutic Drug Monitoring
|
Aug 19, 2022 |
|
#60 – Going MAD for Non-COVID ID Literature: A Year in Review LIVE from MAD-ID
|
Jul 22, 2022 |
|
#59 – Resistance in Pseudomonas aeruginosa: Pearls and Perils
|
Jul 15, 2022 |
|
#58 – We're Gonorrhea-valuate: Updates and Implementation of STI Treatment Guidelines
|
Jun 24, 2022 |
|
#57 – Dosing Consult: Ceftriaxone
|
May 27, 2022 |
|
#56 – Empiric Escalation: Gazing into the Crystal Ball for Multidrug-Resistant Gram-Negatives
|
Apr 15, 2022 |
|
#55 – One World: Global Perspectives in Antimicrobial Stewardship
|
Mar 25, 2022 |
|
#54 – Connecting with our Colleagues: COVID-19 Treatments in Community Pharmacies
|
Mar 18, 2022 |
|
#53 – Abscessus and fortuitum and avium, Oh My!: Updates and Controversies in NTM Management
|
Feb 18, 2022 |
|
#52 – A Conversation with the Authors of IDSA Guidance on Treatment of AmpC, CRAB, and Stenotrophomonas
|
Jan 28, 2022 |
|
#51 – A Conversation with the Authors of IDSA Guidance on Treatment of ESBL, CRE, and DTR Pseudomonas
|
Jan 21, 2022 |
|
#50 – Moving to the Algo-rhythm of IDWeek 2021: Highlights in SoMe and ASP
|
Dec 17, 2021 |
|
#49 – A PGY-What Now? A Primer on ID Pharmacy Fellowships
|
Dec 03, 2021 |
|
#48 – Aligning Goals: Antibiotics in End of Life Care
|
Nov 19, 2021 |
|
#47 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 2
|
Oct 29, 2021 |
|
#46 – A Nefarious Orchestra: Gram-Negative Resistance Mechanisms Part 1
|
Oct 22, 2021 |
|
#45 – Expectation vs. Reality: An Insider look at the OVERCOME and MERINO-2 trials
|
Sep 24, 2021 |
|
#44 – The VaxScene, a review of the COVID-19 vaccine landscape in the US with a focus on equitable distribution and vaccine hesitancy
|
Sep 17, 2021 |
|
#43 – Level Up: Implementation of Beta-lactam Therapeutic Drug Monitoring
|
Aug 27, 2021 |
|
#42 – The Level is in the Details: Beta-lactam Therapeutic Drug Monitoring
|
Aug 20, 2021 |
|
#41 – The Gray Zone: Antimicrobial Stewardship in Immunocompromised Hosts
|
Jul 16, 2021 |
|
#40 – Breakpoints Talks Breakpoints: Microbiology Labs and Stewardship
|
Jun 18, 2021 |
|
#39 – A Little More on the Littles: What Adults Should Know about ID Pediatrics
|
May 21, 2021 |
|
#38 – You're KID-ding! Myths in ID Pediatrics
|
Apr 23, 2021 |
|
#37 – A Gab about Cab: The Short on Long-Acting Antiretrovirals for HIV
|
Apr 16, 2021 |
|
#36 – Monoclonal Antibodies: Gateway Drugs for Future Care Delivery Models
|
Mar 26, 2021 |
|
#35 – Oral Beta-Lactams, Are We Serious?
|
Mar 19, 2021 |
|
#34 – The New Scoop on Poop: Updates in the Management of C. difficile infections
|
Feb 19, 2021 |
|
#33 – A Lung Time Coming: Controversies in Community Acquired Pneumonia
|
Jan 15, 2021 |
|
#32 – Unsolicited Advice: An Honest Discussion of Burnout in Stewardship
|
Dec 18, 2020 |
|
#31 – “Mind the Gap”: Antimicrobial Stewardship at Transitions of Care
|
Nov 20, 2020 |
|
#30 – Is More Better? The Role of Combination Therapy for MRSA
|
Oct 09, 2020 |
|
#29 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 2
|
Sep 11, 2020 |
|
#28 – What You May Have Missed Due to COVID-19: ID Literature Updates 2020 Part 1
|
Sep 04, 2020 |
|
#27 – Expert Updates in Gram Negative Resistance: Q&A Session
|
Jul 31, 2020 |
|
#26 – OPAT - The Final Frontier, Part 2
|
Jun 19, 2020 |
|
#25 – Remdesivir: Ethical and Practical Considerations for Allocation, Tracking, and More
|
Jun 18, 2020 |
|
#24 – OPAT – The Final Frontier, Part 1
|
Jun 12, 2020 |
|
#23 – Taking a “BITE” Out of Antibiotic Prescribing: Strategies to Improve Antimicrobial Usage in Dentistry
|
May 22, 2020 |
|
#22 – Taking a “BITE” Out of Antibiotic Prescribing: The Need for Antimicrobial Stewardship in Dentistry
|
May 15, 2020 |
|
#21 – Frontline Allies: Emergency Medicine and Critical Care Insights into COVID19
|
Apr 27, 2020 |
|
#20 – What is Happening Right Now? COVID-19 Challenges and Silver Linings
|
Apr 13, 2020 |
|
#19 – Push and Pull: Combating Antibiotic Resistance from Discovery to Market Reform
|
Feb 21, 2020 |
|
#18 – Waking the Sleeping Giant: Engaging Nurses in Antimicrobial Stewardship
|
Jan 17, 2020 |
|
#17 – See C. diff: A Discussion on Patient Advocacy
|
Dec 20, 2019 |
|
#16 – 5 Ways Hospital Pharmacists Can Be Antibiotics Aware
|
Nov 20, 2019 |
|
#15 – CDC Core Elements of Hospital Antibiotic Stewardship Programs: 2019 Update
|
Nov 18, 2019 |
|
#14 – Pumpkin-Spiced Lessons: Phages, Posters, and Paul Sax
|
Nov 08, 2019 |
|
#13 – Provocative Titles and Pro-Con Debates
|
Nov 08, 2019 |
|
#12 – Late Breaker Trials and #WhyIVaccinate
|
Nov 01, 2019 |
|
#11 – Practice-changing Publications ft. David van Duin
|
Nov 01, 2019 |
|
#10 – So You're an Antimicrobial Steward... Now What?
|
Jul 31, 2019 |
|
#9 – Show Me the Data!
|
Jul 31, 2019 |
|
#8 – Stewardship is a Team Sport
|
Jul 31, 2019 |
|
#7 – Rapid Fire Data from ECCMID 2019
|
Jul 10, 2019 |
|
#6 – Tazobactam and Tulips: Hot Topics from ECCMID 2019
|
Jul 10, 2019 |
|
#5 – Nerding Out at ECCMID 2019
|
Jul 10, 2019 |
|
#4 – How ECCMID 2019 went viral
|
Jul 10, 2019 |
|
#3 – Lessons Learned From the Front Line
|
Jun 26, 2019 |
|
#2 – Implementing Penicillin Skin Testing
|
Jun 26, 2019 |
|
#1 – Mythbusting
|
Jun 26, 2019 |